The CDKN2A locus (9p21.3) was identified as the only target of recurrent homozygous deletions in both neurofibromas (n = 4, 14%, including the plexiform tumour) and MPNSTs (44%; Supplementary Fig. S4). The gene discussed is CDKN2A; the disease is neurofibroma.